Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides
使用胶原蛋白杂交肽针对胶原蛋白机械损伤
基本信息
- 批准号:10158440
- 负责人:
- 金额:$ 36.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-05 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmino AcidsBindingBiomechanicsCartilageCartilage injuryClinicalCollagenCollagen FibrilDNADegenerative polyarthritisDense Connective TissueDetectionDevelopmentDiffusionDigestionDiseaseElementsEvolutionExhibitsExperimental ModelsFatigueFissuralFutureGoalsHybridsIn SituInflammatory ResponseInjuryKineticsLabelLigamentsMechanical StressMechanicsMethodsMolecularMolecular ProbesMolecular TargetMusculoskeletalMusculoskeletal DiseasesNatureOutcomes ResearchPainPenetrationPeptide HydrolasesPeptidesPredispositionProcessProtocols documentationReactionReportingResearchRotator CuffSensitivity and SpecificitySpecimenStainsStressStructureTechniquesTechnologyTendinopathyTendon structureTimeTissuesTrypsinWeight-Bearing stateWorkarticular cartilagebasecarboxyfluoresceincell injuryclinically relevantclinically significantdetection methoddisabilityenthalpyexperimental studyfluorophoreimprovedin vivo monitoringinsightmacrophagemechanical loadmechanical propertiesmeltingmusculoskeletal injurynext generationnovelnovel diagnosticsnovel therapeuticsresponsesoft tissuesynthetic peptidetargeted deliverytargeted treatment
项目摘要
SUMMARY
Detection of Collagen Mechanical Damage using Collagen Hybridizing Peptides.
Mechanical injury to load-bearing tissues leads to many clinically significant conditions (e.g. tendinosis, rotator
cuff disease) but we have limited understanding of the injury process of tissues that are damaged by mechanical
stress. The overall goal of the proposed research is to gain new understanding of the biomechanics of load
bearing collagenous tissues by developing the collagen hybridizing peptide (CHP) technology into a new
mechanical damage detection method. CHP has been reported to bind to denatured collagen strands originating
from protease activity or by mechanical damage in a manner similar to primer binding to melted DNA during
PCR. We propose to substantially expand the capabilities of CHP damage detection by developing new CHPs
that are smaller for faster diffusion into dense musculoskeletal tissues and exhibit accelerated binding kinetics to
allow faster damage reporting. We will also develop a new CHP that only fluoresces upon binding with collagen,
eliminating the need to stain and wash tissues and enabling the CHP to serve as a damage gauge in overloaded
tissues. We will then develop optimized protocols for the use of the existing and new CHPs, determine the
relationship between collagen fibril strain and CHP binding in musculoskeletal soft tissues, and quantitatively
compare CHP targeting to other techniques. Finally, we will apply CHP targeting to elucidate the relationship
between tissue level mechanical loading and mechanical damage to collagen at the molecular level. We will
focus on two important musculoskeletal tissues of considerable clinical relevance: tendons and articular
cartilage. Considering the wide-spread impact of collagen damage in musculoskeletal injuries and diseases, in-
depth understanding of the relationships between molecular level collagen damage and mechanical overloading
will provide new insights into the biomechanics of load-bearing tissues as well as help develop new diagnostics
and therapies for managing musculoskeletal disorders.
概括
使用胶原蛋白杂交肽检测胶原蛋白机械损伤。
对负荷组织的机械损伤导致许多临床上的重要条件(例如肌腱病,旋转器
袖口疾病),但我们对机械损坏的组织的损伤过程有限
压力。拟议研究的总体目标是对负载的生物力学有了新的了解
通过将胶原蛋白杂交肽(CHP)技术开发为新的胶原组织
机械损伤检测方法。据报道,CHP与成型的胶原蛋白链结合起来
从蛋白酶活性或机械损伤中以类似于底漆与融化DNA结合的方式进行
pcr。我们建议通过开发新的CHP来大大扩大CHP损伤检测的能力
较小的,可以更快地扩散到密集的肌肉骨骼组织中,并表现出加速的结合动力学
允许更快的损坏报告。我们还将开发一种新的CHP,仅在与胶原蛋白结合后才荧光,
消除需要染色和洗涤组织并使CHP充当损伤量表的需求
组织。然后,我们将开发使用现有和新CHP的优化协议,确定
肌肉骨骼软组织中胶原蛋白原纤维应变与CHP结合之间的关系,并定量
将CHP靶向与其他技术进行比较。最后,我们将应用CHP定位以阐明关系
在组织水平的机械负荷和分子水平胶原蛋白的机械损伤之间。我们将
专注于两个重要的临床相关性的两个重要的肌肉骨骼组织:肌腱和关节
软骨。考虑到胶原蛋白损伤对肌肉骨骼损伤和疾病的广泛影响,
深度了解分子水平胶原蛋白损伤与机械超载之间的关系
将为负载组织的生物力学提供新的见解,并有助于开发新的诊断
和管理肌肉骨骼疾病的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY A. WEISS其他文献
JEFFREY A. WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY A. WEISS', 18)}}的其他基金
Lab-to-User Training and Dissemination for the FEBio Software Suite
FEBio 软件套件的实验室对用户培训和传播
- 批准号:
10189583 - 财政年份:2019
- 资助金额:
$ 36.65万 - 项目类别:
Lab-to-User Training and Dissemination for the FEBio Software Suite
FEBio 软件套件的实验室对用户培训和传播
- 批准号:
10401860 - 财政年份:2019
- 资助金额:
$ 36.65万 - 项目类别:
Lab-to-User Training and Dissemination for the FEBio Software Suite
FEBio 软件套件的实验室对用户培训和传播
- 批准号:
10019547 - 财政年份:2019
- 资助金额:
$ 36.65万 - 项目类别:
Lab-to-User Training and Dissemination for the FEBio Software Suite
FEBio 软件套件的实验室对用户培训和传播
- 批准号:
10670059 - 财政年份:2019
- 资助金额:
$ 36.65万 - 项目类别:
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides
使用胶原蛋白杂交肽针对胶原蛋白机械损伤
- 批准号:
10437626 - 财政年份:2018
- 资助金额:
$ 36.65万 - 项目类别:
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides
使用胶原蛋白杂交肽针对胶原蛋白机械损伤
- 批准号:
9926821 - 财政年份:2018
- 资助金额:
$ 36.65万 - 项目类别:
Computational Framework for Multiscale Mechanics of Connective Tissues
结缔组织多尺度力学计算框架
- 批准号:
8439979 - 财政年份:2012
- 资助金额:
$ 36.65万 - 项目类别:
Computational Framework for Multiscale Mechanics of Connective Tissues
结缔组织多尺度力学计算框架
- 批准号:
8727295 - 财政年份:2012
- 资助金额:
$ 36.65万 - 项目类别:
Computational Framework for Multiscale Mechanics of Connective Tissues
结缔组织多尺度力学计算框架
- 批准号:
8554764 - 财政年份:2012
- 资助金额:
$ 36.65万 - 项目类别:
相似国自然基金
氨基酸结合和解离Ubr1的调控机制研究
- 批准号:32300990
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
精准挖掘水稻生长素受体OsAFB4结合生长素类除草剂的关键氨基酸靶点
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
嗜热子囊菌TaAA9A关键氨基酸介导的结晶纤维素结合与降解机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
精准挖掘水稻生长素受体OsAFB4结合生长素类除草剂的关键氨基酸靶点
- 批准号:32201834
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 36.65万 - 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 36.65万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 36.65万 - 项目类别:
Development of peptide drug conjugates for cancer therapy
开发用于癌症治疗的肽药物缀合物
- 批准号:
10760236 - 财政年份:2023
- 资助金额:
$ 36.65万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 36.65万 - 项目类别: